Status:

UNKNOWN

Early Detection and Intervention for Women At-risk of Psychosis

Lead Sponsor:

The University of Hong Kong

Conditions:

Prodromal Schizophrenia

Eligibility:

FEMALE

18-64 years

Phase:

NA

Brief Summary

This study aims to examine the effectiveness of the cognitive behavioral therapy in preventing the conversion of psychosis in a sample of individuals at-risk for psychosis.

Detailed Description

Eligible subjects with informed consent provided will be randomly assigned to the cognitive behavioural therapy (CBT) group or psychoeducation group. Each group consists of 8 session spanning for 8 we...

Eligibility Criteria

Inclusion

  • women of age 18-64
  • at-risk mental state as defined by the Comprehensive Assessment of At-Risk Mental States (CAARMS)
  • with an informed consent
  • able to understand Cantonese and read/write Chinese

Exclusion

  • those mental conditions that requires other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)
  • those medical conditions that severely limits participation, comprehension, or adherence to the treatment (e.g., epilepsy, dementia, terminal medical illness);
  • those who are receiving structured psychotherapy or counselling

Key Trial Info

Start Date :

November 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2023

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT03751865

Start Date

November 15 2018

End Date

August 30 2023

Last Update

April 20 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Hong Kong

Hong Kong, Hong Kong, 0000